FRAXIDIN
UNII E674PBX5B8

Substance Identification & Data

This profile provides standardized clinical and technical data for Fraxidin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) E674PBX5B8.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 525-21-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
E674PBX5B8
CAS Registry Number
525-21-3
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
FRAXIDIN
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C11H10O5
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
QNFBKOHHLAWWTC-UHFFFAOYSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
COc1c(OC)c(c2oc(=O)ccc2c1)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Fraxidin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

FRAXIDIN

Systematic Nomenclature

2H-1-BENZOPYRAN-2-ONE, 8-HYDROXY-6,7-DIMETHOXY-
8-HYDROXY-6,7-DIMETHOXY-2H-1-BENZOPYRAN-2-ONE
COUMARIN, 8-HYDROXY-6,7-DIMETHOXY-